- Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). Skarin, A.T., Canellos, G.P., Rosenthal, D.S., Case, D.C., MacIntyre, J.M., Pinkus, G.S., Moloney, W.C., Frei, E. J. Clin. Oncol. (1983)